Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design.

Wang X, Liu J, Hairulajiang A, Wang J, Wang Q, Li Z, Zou B, Feng Y

Open source

DOI
10.1186/s12943-026-02786-4
Published
2026 Sep 20
Container
Molecular cancer
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12943-026-02786-4,
  title = {Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design.},
  author = {Wang X and Liu J and Hairulajiang A and Wang J and Wang Q and Li Z and Zou B and Feng Y},
  year = {2026},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-026-02786-4},
  url = {https://doi.org/10.1186/s12943-026-02786-4}
}

RIS

TY  - JOUR
TI  - Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design.
AU  - Wang X
AU  - Liu J
AU  - Hairulajiang A
AU  - Wang J
AU  - Wang Q
AU  - Li Z
AU  - Zou B
AU  - Feng Y
PY  - 2026
JO  - Molecular cancer
DO  - 10.1186/s12943-026-02786-4
UR  - https://doi.org/10.1186/s12943-026-02786-4
ER  - 

APA

X, W., J, L., A, H., J, W., Q, W., Z, L., B, Z., & Y, F. (2026). Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design.. Molecular cancer. https://doi.org/10.1186/s12943-026-02786-4

Source records